Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated:  12/31/1969
Sooner Clinical Research
mi
from
Oklahoma City, OK
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated: 12/31/1969
Sooner Clinical Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated:  12/31/1969
Lynn Health Science Institute
mi
from
Oklahoma City, OK
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated: 12/31/1969
Lynn Health Science Institute
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated:  12/31/1969
FutureSearch Trials of Neurology
mi
from
Austin, TX
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated: 12/31/1969
FutureSearch Trials of Neurology
mi
from
Austin, TX
Click here to add this to my saved trials
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated:  12/31/1969
NEA Baptist Clinic
mi
from
Jonesboro, AR
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated: 12/31/1969
NEA Baptist Clinic
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Trials, Inc.
mi
from
Little Rock, AR
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Trials, Inc.
mi
from
Little Rock, AR
Click here to add this to my saved trials
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated:  12/31/1969
Viking Clinical Research Center
mi
from
Murrieta, CA
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated: 12/31/1969
Viking Clinical Research Center
mi
from
Murrieta, CA
Click here to add this to my saved trials
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated:  12/31/1969
Neurological Research Institute
mi
from
Santa Monica, CA
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated: 12/31/1969
Neurological Research Institute
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated:  12/31/1969
Viking Clinical Research Center
mi
from
Temecula, CA
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated: 12/31/1969
Viking Clinical Research Center
mi
from
Temecula, CA
Click here to add this to my saved trials
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated:  12/31/1969
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated: 12/31/1969
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Click here to add this to my saved trials
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated:  12/31/1969
Scott and White Healthcare-Office of Sponsored Research Administration
mi
from
Temple, TX
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated: 12/31/1969
Scott and White Healthcare-Office of Sponsored Research Administration
mi
from
Temple, TX
Click here to add this to my saved trials
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated:  12/31/1969
Scott and White Healthcare
mi
from
Temple, TX
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated: 12/31/1969
Scott and White Healthcare
mi
from
Temple, TX
Click here to add this to my saved trials
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated:  12/31/1969
Fundacion Argentina Contra las Enfermedades Neurologicas (FACENE)
mi
from
Ciudad Autonoma de Buenos Aires,
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated: 12/31/1969
Fundacion Argentina Contra las Enfermedades Neurologicas (FACENE)
mi
from
Ciudad Autonoma de Buenos Aires,
Click here to add this to my saved trials
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated:  12/31/1969
Optima Neurological Services, LLC
mi
from
Gainesville, FL
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated: 12/31/1969
Optima Neurological Services, LLC
mi
from
Gainesville, FL
Click here to add this to my saved trials
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated:  12/31/1969
Sleep Disorders Center of Georgia - Gainesville
mi
from
Gainesville, GA
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated: 12/31/1969
Sleep Disorders Center of Georgia - Gainesville
mi
from
Gainesville, GA
Click here to add this to my saved trials
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated:  12/31/1969
Veroniqe Sebastian, MD
mi
from
Oklahoma City, OK
Once-A-Day Pregabalin For Partial Seizures
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures
Status: Enrolling
Updated: 12/31/1969
Veroniqe Sebastian, MD
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols
Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute (NCI) Clinical Research Protocols
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols
Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute (NCI) Clinical Research Protocols
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Phoenix Neurological Associates
mi
from
Phoenix, AZ
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Phoenix Neurological Associates
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Barrow Neurology Clinic
mi
from
Phoenix, AZ
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Barrow Neurology Clinic
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
HOPE Research Institute
mi
from
Phoenix, AZ
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
HOPE Research Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Sutter East Bay Medical Foundation
mi
from
Berkeley, CA
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Sutter East Bay Medical Foundation
mi
from
Berkeley, CA
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
MS Center of Southern California
mi
from
Newport Beach, CA
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
MS Center of Southern California
mi
from
Newport Beach, CA
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Univ of CA Davis Med Ctr; Neurology
mi
from
Sacramento, CA
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Univ of CA Davis Med Ctr; Neurology
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Univ of CA San Francisco; Department of Neurology
mi
from
San Francisco, CA
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Univ of CA San Francisco; Department of Neurology
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of Colorado Anschutz Medical Campus - Department of Neurology
mi
from
Aurora, CO
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Colorado Anschutz Medical Campus - Department of Neurology
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Bradenton Research Center
mi
from
Bradenton, FL
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Bradenton Research Center
mi
from
Bradenton, FL
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Neurology Associates, PA; Research Department
mi
from
Maitland, FL
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Neurology Associates, PA; Research Department
mi
from
Maitland, FL
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of Miami School of Medicine; Dept. of Neurology Movement Disorder Center
mi
from
Miami, FL
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Miami School of Medicine; Dept. of Neurology Movement Disorder Center
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Axiom Clinical Research of Florida
mi
from
Tampa, FL
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Axiom Clinical Research of Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
MS Center of Vero Beach
mi
from
Vero Beach, FL
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
MS Center of Vero Beach
mi
from
Vero Beach, FL
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Emory University Clinic
mi
from
Atlanta, GA
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Emory University Clinic
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
MS Center of Atlanta
mi
from
Atlanta, GA
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
MS Center of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
MidAmerica Neuroscience Institute
mi
from
Prairie Village, KA
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
MidAmerica Neuroscience Institute
mi
from
Prairie Village, KA
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Wayne State University, Department of Neurology
mi
from
Detroit, MI
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Wayne State University, Department of Neurology
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Henry Ford Health System; Neurology & Neurosurgery
mi
from
Detroit, MI
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Henry Ford Health System; Neurology & Neurosurgery
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Michigan Institute for Neurological Disorders
mi
from
Farmington Hills, MI
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Michigan Institute for Neurological Disorders
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Minneapolis Clinic of Neurology
mi
from
Golden Valley, MN
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Minneapolis Clinic of Neurology
mi
from
Golden Valley, MN
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of Minnesota; Clin. Neuro Research Unit
mi
from
Minneapolis, MN
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Minnesota; Clin. Neuro Research Unit
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine; Department of Neurology
mi
from
Saint Louis, MO
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine; Department of Neurology
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Holy Name Hospital
mi
from
Teaneck, NJ
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Holy Name Hospital
mi
from
Teaneck, NJ
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of New Mexico; MS Specialty Clinic
mi
from
Albuquerque, NM
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of New Mexico; MS Specialty Clinic
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Albany Medical College; Neurology
mi
from
Albany, NY
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Albany Medical College; Neurology
mi
from
Albany, NY
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Winthrop University Hospital
mi
from
Mineola, NY
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Weill Medical College of Cornell University; Judith Jaffe MS Ctr
mi
from
New York, NY
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Weill Medical College of Cornell University; Judith Jaffe MS Ctr
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Mount Sinai School of Medicine; Neurology
mi
from
New York, NY
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Mount Sinai School of Medicine; Neurology
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Comprehensive MS Care Center at South Shore Neurologic Assoc.
mi
from
Patchogue, NY
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Comprehensive MS Care Center at South Shore Neurologic Assoc.
mi
from
Patchogue, NY
Click here to add this to my saved trials
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of Rochester-Strong Memorial Hospital
mi
from
Rochester, NY
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Rochester-Strong Memorial Hospital
mi
from
Rochester, NY
Click here to add this to my saved trials